Monitoring Glucose Levels in Patients With Myocardial Infarction

COMGAMI Continuous Monitoring of Glucose in Acute Myocardial Infarction

To evaluate the OptiScanner® for continuous glucose monitoring as a tool to optimize glucose levels in patients hospitalized for acute coronary syndromes

Methodology Part a) Explorative Part b) Randomised, parallel-group design

Inclusion Criteria:

• Acute coronary syndrome according to the joint recommendations by the European Society of Cardiology (48, 49)
• Signed written informed consent consistent with Helsinki declaration and local legislations prior to participation in the trial.

Exclusion Criteria:

• <18 years old.
• Congestive heart failure.
• Patients who, in the opinion of the investigator, will have difficulties to comply with the protocol (examples: alcohol or drug abuse, psychiatric disorder).